DC260126

CAS No. 346692-04-4

DC260126( —— )

Catalog No. M20675 CAS No. 346692-04-4

DC260126 is a small-molecule antagonist of FFA1 (GPR40).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
5MG 48 In Stock
10MG 63 In Stock
25MG 137 In Stock
50MG 211 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DC260126
  • Note
    Research use only, not for human use.
  • Brief Description
    DC260126 is a small-molecule antagonist of FFA1 (GPR40).
  • Description
    DC260126 is a small-molecule antagonist of FFA1 (GPR40) .
  • In Vitro
    DC260126 reduces GTP-loading and ERK1/2 phosphorylation stimulated by linoleic acid in GPR40-CHO cells, suppresses palmitic acid potentiated glucose-stimulated insulin secretion, and negatively regulates GPR40 mRNA expression induced by oleic acid in Min6 cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR40
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    346692-04-4
  • Formula Weight
    307.38
  • Molecular Formula
    C16H18FNO2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (325.33 mM)
  • SMILES
    CCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Peng S Ting W Yuren Z et al. DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic β-Cells Dysfunction in db/db Mice[J]. PLoS ONE 2013 8(6):e66744-.
molnova catalog
related products
  • BI-671800

    BI-671800 is a highly specific and potent antagonist of chemoattractant receptor-homologous molecule on Th2 cells (DP2/CRTH2).

  • FL104

    FL104 is a potent agonist of small-molecule urotensin II receptor, pEC50= 7.11.

  • TAK-041

    TAK-041 is a potent and selective GPR139 agonist.